Drug Profile
Research programme: flavivirus NS2B/NS3 protease inhibitors - Microbial Novoteqs
Latest Information Update: 28 Aug 2020
Price :
$50
*
At a glance
- Originator Microbial Novoteqs
- Class Antivirals
- Mechanism of Action Peptide hydrolase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Dengue; West Nile virus infections; Yellow fever
Most Recent Events
- 28 Aug 2020 No recent reports of development identified for research development in Dengue in USA
- 28 Aug 2020 No recent reports of development identified for research development in West Nile virus infections in USA
- 28 Aug 2020 No recent reports of development identified for research development in Yellow-fever in USA